Clinical trial
Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis…
NCT00004755 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00004755 |
|---|---|
| Title | Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil |
| Official title | Phase II Randomized Study of Allopurinol Versus Glucantime Versus Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Harvard School of Public Health (HSPH) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leishmaniasis |
| Intervention type | Drug |
| Interventions | allopurinol, glucantime |
| Enrollment | 375 |
| Start date | Sep 1, 1995 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: